Insulet Corporation Reports Strong Q1 2026 Performance with Revenue Growth

Insulet Corporation reported strong financial performance for the first quarter of 2026, achieving a 30% constant currency revenue growth driven by international expansion and adoption of Omnipod 5. The company raised its full-year revenue guidance to 21%-23%, citing confidence in recurring revenue models and upcoming product integrations.

By Moby Intelligence Wed, May 6, 2026 at 8:00 PM GMT+3 3 min read · Yahoo Finance ·

Insulet Corporation Reports Strong Q1 2026 Performance with Revenue Growth

Tickers: $PODD

Topics: clinical_strategy international_expansion product_launches revenue_growth

Read the full article at Yahoo Finance

More World news